Search for: "Teva Pharmaceutical" Results 781 - 800 of 1,429
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Sep 2012, 9:59 pm by Patent Docs
Teva Branded Pharmaceutical Products R&D Inc. et al. v. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  In a December 2011 Complaint, several direct purchasers allege that Wyeth, acting alone and/or in concert with first generic applicant Teva Pharmaceuticals USA, Inc. [read post]
27 Aug 2012, 9:31 am by Gene Quinn
" This dispute arose when Teva Parenteral Medicines, Inc., Barr Laboratories, Inc., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
27 Aug 2012, 9:31 am by Gene Quinn
" This dispute arose when Teva Parenteral Medicines, Inc., Barr Laboratories, Inc., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
24 Aug 2012, 3:00 pm by Mandour & Associates
.'s patent for its chemotherapy treatment Alimta, rejecting a challenge from generic drug makers Teva Parenteral Medicines Inc., Barr Laboratories Inc. and APP Pharmaceuticals Inc. [read post]
24 Aug 2012, 2:57 pm
.'s patent for the chemotherapy drug pemetrexed, marketed under the name Alimta, is valid, overruling a challenge from generic pharmaceutical makers Teva Parenteral Medicines Inc., Barr Laboratories Inc. and APP Pharmaceuticals Inc. [read post]
23 Aug 2012, 12:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2010 WL 8357563, slip op. at 1-2 (Tex. [read post]
15 Aug 2012, 11:02 am by FDABlog HPM
According to Watson, “[b]ased on the simultaneous filing of the Watson ANDA with Mylan and Ranbaxy’s ANDAs, Watson has expected to share the period of 180-day exclusivity with Mylan and Ranbaxy (as well as with a fourth generic manufacturer, Teva Pharmaceuticals (‘Teva’), that has been granted a license by Takeda). [read post]
14 Aug 2012, 8:50 pm
This posting was written by Cheryl Beise, Contributor to IP Law Daily.The Federal Trade Commission announced yesterday that it has filed an Amicus Brief with the federal district court in Trenton, New Jersey in the Effexor XR Antitrust Litigation to challenge an agreement between Wyeth and Teva Pharmaceuticals as an illegal restraint of trade. [read post]
14 Aug 2012, 8:50 pm
This posting was written by Cheryl Beise, Contributor to IP Law Daily.The Federal Trade Commission announced yesterday that it has filed an Amicus Brief with the federal district court in Trenton, New Jersey in the Effexor XR Antitrust Litigation to challenge an agreement between Wyeth and Teva Pharmaceuticals as an illegal restraint of trade. [read post]
14 Aug 2012, 8:50 pm
This posting was written by Cheryl Beise, Contributor to IP Law Daily.The Federal Trade Commission announced yesterday that it has filed an Amicus Brief with the federal district court in Trenton, New Jersey in the Effexor XR Antitrust Litigation to challenge an agreement between Wyeth and Teva Pharmaceuticals as an illegal restraint of trade. [read post]
14 Aug 2012, 5:00 am by ipelton
"] Deckers Outdoor Corporation [Note: makers of UGGs, Teva, and other brands]  ["We encourage IPEC to actively support legislation that gives companies the legal tools they need to protect their brands and keep dangerous goods out of the hands of consumers.] [read post]
3 Aug 2012, 1:56 pm by Joe Palazzolo
The Securities and Exchange Commission is investigating Teva Pharmaceutical Industries Ltd, the world’s largest manufacturer of generic drugs, for possible violations of a U.S. anti-bribery law. [read post]
23 Jul 2012, 3:30 am
In her lawsuit, Klopp names both Wyeth (the company which makes the name-brand version of the drug) and Schwarz Pharma and Teva Pharmaceuticals (the companies which make the generic version of Reglan) as defendants. [read post]
18 Jul 2012, 4:52 am
In the pharmaceutical field, for example, a patent can be granted based on in vitro results. [read post]
25 Jun 2012, 6:16 am by Mark Zamora
Adderall is approved by the FDA to treat attention-deficit hyperactivity disorder and narcolepsy.The FDA became aware of the problem when Teva Pharmaceutical Industries reported that a consumer alerted them about purchasing a fake version of Teva's Adderall 30-milligram tablets from an illegal Internet pharmaceutical site.http://www.ketknbc.com/news/fda-issues-warning-about-counterfeit-adderall-purchased-online-0 [read post]